Publication | Open Access

Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)

Phase IiNon-small-cell Lung CancerMedicinePathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyCancer ResearchLung CancerMolecular Oncology